4.7 Article

Lipoprotein(a) and SARS-CoV-2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Medical Laboratory Technology

Lipoprotein(a) and Cardiovascular Disease

Pia R. Kamstrup

Summary: This review article presents evidence from large genetic epidemiologic studies supporting a causal role of high lipoprotein(a) concentrations in cardiovascular disease, and discusses measurements of lipoprotein(a) and potential treatment options. Further research is needed to confirm causality and evaluate the clinical benefits of lowering therapies.

CLINICAL CHEMISTRY (2021)

Article Medicine, General & Internal

Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis

Aaron Leong et al.

Summary: This study used Mendelian randomization analyses to test the causal relationship between 17 cardiometabolic diseases and traits with COVID-19 illness. The findings suggest that higher body mass index is associated with a higher risk of hospitalization for COVID-19, possibly mediated by obesity-related cardiometabolic diseases.

PLOS MEDICINE (2021)

Letter Cardiac & Cardiovascular Systems

Genetic Predictor to Identify Individuals With High Lipoprotein(a) Concentrations

Jacqueline S. Dron et al.

CIRCULATION-GENOMIC AND PRECISION MEDICINE (2021)

Editorial Material Cardiac & Cardiovascular Systems

Mechanistic insights into lipoprotein infamous to 'inflammous'

Stefan Coassin et al.

EUROPEAN HEART JOURNAL (2020)

Letter Medicine, General & Internal

Familial hypercholesterolaemia and COVID-19: triggering of increased sustained cardiovascular risk

Alpo Vuorio et al.

JOURNAL OF INTERNAL MEDICINE (2020)

Article Medicine, General & Internal

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Maximilian Ackermann et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Peripheral Vascular Disease

Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis

Patrick M. Moriarty et al.

CURRENT ATHEROSCLEROSIS REPORTS (2020)

Article Cardiac & Cardiovascular Systems

Thromboembolic Complications in Patients With COVID-19

Gregory Piazza et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Article Biochemistry & Molecular Biology

A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms

Salome Mack et al.

JOURNAL OF LIPID RESEARCH (2017)

Article Endocrinology & Metabolism

Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis

Danish Saleheen et al.

LANCET DIABETES & ENDOCRINOLOGY (2017)

Review Biochemistry & Molecular Biology

Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

Borge G. Nordestgaard et al.

JOURNAL OF LIPID RESEARCH (2016)

Review Medicine, General & Internal

Lipoprotein(a): resurrected by genetics

F. Kronenberg et al.

JOURNAL OF INTERNAL MEDICINE (2013)